Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


11.03.2019

1 Am J Hematol
1 Biochem Biophys Res Commun
1 Blood
1 BMC Cancer
1 Bone Marrow Transplant
1 Br J Haematol
2 Cancer
1 Eur J Haematol
6 Haematologica
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Am Acad Dermatol
1 Lancet Oncol
3 Leuk Lymphoma
1 Oncogene
1 PLoS Genet
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. MAURA F, Agnelli L, Leongamornlert D, Bolli N, et al
    Integration of Transcriptional and Mutational Data Simplifies the Stratification of Peripheral T-Cell Lymphoma.
    Am J Hematol. 2019 Mar 4. doi: 10.1002/ajh.25450.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. WANG R, Wang J, Zhang N, Wan Y, et al
    The interaction between Vav1 and EBNA1 promotes survival of Burkitt's lymphoma cells by down-regulating the expression of Bim.
    Biochem Biophys Res Commun. 2019 Mar 1. pii: S0006-291X(19)30309.
    PubMed     Text format     Abstract available


    Blood

  3. ALLAN JM
    Genetic susceptibility to breast cancer in lymphoma survivors.
    Blood. 2019;133:1004-1006.
    PubMed     Text format    


    BMC Cancer

  4. BONOU M, Kapelios CJ, Marinakos A, Adamopoulos S, et al
    Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report.
    BMC Cancer. 2019;19:191.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  5. HOLDERRIED TAW, Fraccaroli A, Schumacher M, Heine A, et al
    The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0498.
    PubMed     Text format     Abstract available


    Br J Haematol

  6. CHEN L, Li S, Wang M, Li Y, et al
    Expansion deficiency of CAR-T cells in patients with lymphoma and resolution by T cell purification.
    Br J Haematol. 2019 Mar 4. doi: 10.1111/bjh.15822.
    PubMed     Text format    


    Cancer

  7. MRDENOVIC S, Zhang Y, Wang R, Yin L, et al
    Targeting Burkitt lymphoma with a tumor cell-specific heptamethine carbocyanine-cisplatin conjugate.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32033.
    PubMed     Text format     Abstract available

  8. DENBURG AE, Laher N, Mutyaba I, McGoldrick S, et al
    The cost effectiveness of treating Burkitt lymphoma in Uganda.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32006.
    PubMed     Text format     Abstract available


    Eur J Haematol

  9. VAHAMURTO P, Mannisto S, Pollari M, Karjalainen-Lindsberg ML, et al
    Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre and rituximab eras.
    Eur J Haematol. 2019 Mar 4. doi: 10.1111/ejh.13225.
    PubMed     Text format     Abstract available


    Haematologica

  10. WANG X, Chen Z, Mishra AK, Silva A, et al
    Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition.
    Haematologica. 2018;103:466-476.
    PubMed     Text format     Abstract available

  11. LEMONNIER F, Poullot E, Dupuy A, Couronne L, et al
    Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas.
    Haematologica. 2018;103:e115-e118.
    PubMed     Text format    

  12. NIJLAND ML, Koens L, Pals ST, Berge IJMT, et al
    Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature.
    Haematologica. 2018;103:486-496.
    PubMed     Text format     Abstract available

  13. STEEN CB, Leich E, Myklebust JH, Lockmer S, et al
    A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.
    Haematologica. 2019 Mar 7. pii: haematol.2018.209080.
    PubMed     Text format    

  14. GRANAI M, Ambrosio MR, Akarca A, Mundo L, et al
    Role of Epstein Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.
    Haematologica. 2019 Mar 7. pii: haematol.2018.215053.
    PubMed     Text format    

  15. ROSSI D, Spina V, Bruscaggin A, Gaidano G, et al
    Liquid biopsy in lymphoma.
    Haematologica. 2019 Mar 7. pii: haematol.2018.206177.
    PubMed     Text format    


    Int J Cancer

  16. JOKO-FRU WY, Parkin DM, Borok M, Chokunonga E, et al
    Survival from childhood cancers in Eastern Africa: A population-based registry study.
    Int J Cancer. 2018;143:2409-2415.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  17. TUMATI V, Trivedi L, Li HC, Patel P, et al
    Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:1126-1132.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  18. XIA FD, Ferket BS, Huang V, Stern RS, et al
    Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States.
    J Am Acad Dermatol. 2019;80:485-492.
    PubMed     Text format     Abstract available


    Lancet Oncol

  19. MAKITA S, Tobinai K
    Targeting EZH2 with tazemetostat.
    Lancet Oncol. 2018;19:586-587.
    PubMed     Text format    


    Leuk Lymphoma

  20. JANTUNEN E, Varmavuo V, Pelkonen J, Valtola J, et al
    Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients.
    Leuk Lymphoma. 2019 Mar 7:1-7. doi: 10.1080/10428194.2019.1581929.
    PubMed     Text format     Abstract available

  21. GOPALSAMY SN, Rosenthal KM, Ayers AA, Goy A, et al
    Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma.
    Leuk Lymphoma. 2019 Mar 8:1-9. doi: 10.1080/10428194.2019.1574006.
    PubMed     Text format     Abstract available

  22. CHO SK, McCombs J, Punwani N, Lam J, et al
    Complications and hospital costs during hematopoietic stem cell transplantation for non-Hodgkin lymphoma in the United States.
    Leuk Lymphoma. 2019 Mar 8:1-7. doi: 10.1080/10428194.2019.1581932.
    PubMed     Text format     Abstract available


    Oncogene

  23. HU T, Chong Y, Qin H, Kitamura E, et al
    The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
    Oncogene. 2018;37:1926-1938.
    PubMed     Text format     Abstract available


    PLoS Genet

  24. GOUVEIA MH, Bergen AW, Borda V, Nunes K, et al
    Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt".
    PLoS Genet. 2019;15:e1008027.
    PubMed     Text format     Abstract available


    PLoS One

  25. BERZACZY D, Haug AR, Raderer M, Kiesewetter B, et al
    Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study.
    PLoS One. 2019;14:e0213551.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: